Iitri - non-GLP dose range finding (DRF) studies-DEC. 2023 #2
Ended Awarded Last action
- Contract number
- 75N95024F00004
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $201,969
Award facts
- Opportunity
-
- 75N95024R00029 Solicitation number
- Contract value 100% obligated
- $201,969.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Original award | $201,969 |
About this award
This federal contract award is for $201,969.00 and was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit subsidiary of the Illinois Institute of Technology. The contract is for non-GLP dose range finding (DRF) studies to be completed by December 2023. This appears to be a task order issued under IITRI's $174.5 million single-award Pharmacology and Toxicology for Therapeutics Program contract with NINDS, which enables the agency to efficiently access IITRI's preclinical research capabilities on an as-needed basis. The contract has a cost plus fixed fee pricing type and a completion date of June 2, 2025. No set-aside designation was used for this award.
Quick answers
Who was awarded contract 75N95024F00004?
75N95024F00004 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on July 22, 2024.
How much is contract 75N95024F00004 worth?
The government has obligated $201,969 on 75N95024F00004.
Which agency awarded contract 75N95024F00004?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00004, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95024F00004 an order under another contract?
Yes. 75N95024F00004 is a delivery order under 75N95021D00026, an indefinite delivery contract.
Was contract 75N95024F00004 competed?
The extent of competition for 75N95024F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award